Cargando…
New tumor suppressor microRNAs target glypican-3 in human liver cancer
Glypican-3 (GPC3) is an oncogene, frequently upregulated in liver malignancies such as hepatocellular carcinoma (HCC) and hepatoblastoma and constitutes a potential molecular target for therapy in liver cancer. Using a functional screening system, we identified 10 new microRNAs controlling GPC3 expr...
Autores principales: | Cartier, Flora, Indersie, Emilie, Lesjean, Sarah, Charpentier, Justine, Hooks, Katarzyna B., Ghousein, Amani, Desplat, Angélique, Dugot-Senant, Nathalie, Trézéguet, Véronique, Sagliocco, Francis, Hagedorn, Martin, Grosset, Christophe F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522324/ https://www.ncbi.nlm.nih.gov/pubmed/28476031 http://dx.doi.org/10.18632/oncotarget.17162 |
Ejemplares similares
-
Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo
por: Indersie, Emilie, et al.
Publicado: (2018) -
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β‐catenin and Wnt signaling
por: Indersie, Emilie, et al.
Publicado: (2017) -
Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model
por: Jalvy-Delvaille, Sandra, et al.
Publicado: (2012) -
Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008) -
Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
por: Han, Shiwei, et al.
Publicado: (2016)